Abstract
A number of association studies have investigated the role of the nitric oxide synthase 3 (NOS3) gene in the development of diabetic nephropathy (DN). However, results have been inconclusive, largely because the studies have focused on a variety of different polymorphisms and generate inconsistent results. We performed a meta-analysis of 28 association studies focusing on three polymorphisms in the NOS3 gene (G894T (Glu289Asp), 4b/a, and T-786C) and the risk of DN published before July 2009, covering a total of 10,364 subjects. Although significant heterogeneity was initially found in the analysis of G894T, it did not remain when analysis was done by ethnic subgroups. 894T was negatively associated with DN in Caucasian populations of European origin (OR = 0.896, 0.817–0.983, 95% CI), but was positively associated with DN in East Asian (OR = 2.02, 1.20–3.42, 95% CI) and other populations. Association of the 4b/a variant was observed when studies involving microalbuminuria were excluded (OR = 1.19, 1.02–1.39, 95% CI). The T-786C variant showed an overall weak association (OR = 1.16, 1.01–1.34, 95% CI) with little heterogeneity. In summary, our meta-analysis of the effect of NOS3 gene polymorphisms on the risk of DN supports the involvement of the NOS3 gene in the pathogenesis of DN.
Similar content being viewed by others
Abbreviations
- DN:
-
Diabetic nephropathy
- DWN:
-
Diabetes without nephropathy
- DM:
-
Diabetes mellitus
- NOS3:
-
Nitric oxide synthase 3
- ESRD:
-
End-stage renal disease
- VNTR:
-
Variable number tandem repeat
- LD:
-
Linkage disequilibrium
- NADT:
-
No antihypertensive drug treatment
- SI:
-
South Indian
- NI:
-
North Indian
- RFLP:
-
Restriction fragment length polymorphism
- TDT:
-
Transmission disequilibrium test
References
Ahluwalia TS, Ahuja M, Rai TS et al (2008) Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians. Mol Cell Biochem 314(1–2):9–17
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101
Cai H, Wang X, Colagiuri S, Wilcken DE (1998) A common Glu298 → Asp (894G → T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes. Diabetes Care 21(12):2195–2196
Canani LH, Gerchman F, Gross JL (1999) Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes 48(4):909–913
Degen B, Schmidt S, Ritz E (2001) A polymorphism in the gene for the endothelial nitric oxide synthase and diabetic nephropathy. Nephrol Dial Transplant 16(1):185
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
Dong JJ, Zhao JJ, Lee KO, Lir MC, Chan SW, Liao L (2007) Distribution of polymorphism in endothelial nitric oxide synthase gene in Singapore Chinese and its association with diabetic nephropathy. Zhonghua Yi Xue Za Zhi 87(48):3415–3417
Egger M, Davey Smith G, Schneider M, Minder C (1997a) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G (1997b) Language bias in randomised controlled trials published in English and German. Lancet 350(9074):326–329
Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY (2008) Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy. J Diabetes Complications 22(5):331–338
Fairchild TA, Fulton D, Fontana JT, Gratton JP, McCabe TJ, Sessa WC (2001) Acidic hydrolysis as a mechanism for the cleavage of the Glu(298) → Asp variant of human endothelial nitric-oxide synthase. J Biol Chem 276(28):26674–26679
Freedman BI, Bostrom M, Daeihagh P, Bowden DW (2007) Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol 2(6):1306–1316
Fujita H, Narita T, Meguro H et al (2000) Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy. Horm Metab Res 32(2):80–83
Harrison DG (1997) Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100(9):2153–2157
Jacobs C, Selwood NH (1995) Renal replacement therapy for end-stage renal failure in France: current status and evolutive trends over the last decade. Am J Kidney Dis 25(1):188–195
Jawa A, Kcomt J, Fonseca VA (2004) Diabetic nephropathy and retinopathy. Med Clin North Am 88(4):1001–1036
Kanetsuna Y, Takahashi K, Nagata M et al (2007) Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am J Pathol 170(5):1473–1484
Kankova K, Stejskalova A, Pacal L et al (2007) Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach. Diabetologia 50(5):990–999
Klahr S (2001) The role of nitric oxide in hypertension and renal disease progression. Nephrol Dial Transplant 16(Suppl 1):60–62
Komatsu M, Kawagishi T, Emoto M et al (2002) ecNOS gene polymorphism is associated with endothelium-dependent vasodilation in Type 2 diabetes. Am J Physiol Heart Circ Physiol 283(2):H557–H561
Ksiazek P, Wojewoda P, Muc K, Buraczynska M (2003) Endothelial nitric oxide synthase gene intron 4 polymorphism in type 2 diabetes mellitus. Mol Diagn 7(2):119–123
Li C, Dong Y, Lu W (2001) The association between polymorphism of endothelial nitric oxide synthase gene and diabetic nephropathy. Zhonghua Nei Ke Za Zhi 40(11):729–732
Lin S, Qu H, Qiu M (2002) Allele A in intron 4 of ecNOS gene will not increase the risk of diabetic nephropathy in type 2 diabetes of Chinese population. Nephron 91(4):768
Liu Y, Burdon KP, Langefeld CD et al (2005) T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study. J Am Soc Nephrol 16(4):1085–1090
Mamoulakis D, Bitsori M, Galanakis E, Vazgiourakis V, Panierakis C, Goulielmos GN (2009) Intron 4 polymorphism of the endothelial nitric oxide synthase eNOS gene and early microangiopathy in type 1 diabetes. Int J Immunogenet 36(3):153–157
Miyamoto Y, Saito Y, Nakayama M et al (2000) Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a −786T → C mutation associated with coronary spastic angina. Hum Mol Genet 9(18):2629–2637
Mohan S, Reddick RL, Musi N et al (2008) Diabetic eNOS knockout mice develop distinct macro- and microvascular complications. Lab Invest 88(5):515–528
Mollsten A, Wessman M, Svensson M et al (2006) Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy. Ann Med 38(7):522–528
Mollsten A, Lajer M, Jorsal A, Tarnow L (2009) The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes. Mol Genet Metab 97(1):80–84
Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. N Engl J Med 329(27):2002–2012
Nakagawa T (2007) Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease. Am J Physiol Renal Physiol 292(6):F1665–F1672
Nakagawa T, Sato W, Glushakova O et al (2007) Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 18(2):539–550
Nakayama M, Yasue H, Yoshimura M et al (1999) T-786 → C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99(22):2864–2870
Nath SD, He X, Voruganti VS et al (2009) The 27-bp repeat polymorphism in intron 4 (27 bp-VNTR) of endothelial nitric oxide synthase (eNOS) gene is associated with albumin to creatinine ratio in Mexican Americans. Mol Cell Biochem 331(1–2):201–205
Neugebauer S, Baba T, Watanabe T (2000) Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 49(3):500–503
Noiri E, Satoh H, Taguchi J et al (2002) Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 40(4):535–540
Ohtoshi K, Yamasaki Y, Gorogawa S et al (2002) Association of (-)786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance. Diabetologia 45(11):1594–1601
Palm F, Teerlink T, Hansell P (2009) Nitric oxide and kidney oxygenation. Curr Opin Nephrol Hypertens 18(1):68–73
Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS (2003) Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348(23):2285–2293
Prabhakar SS (2004) Role of nitric oxide in diabetic nephropathy. Semin Nephrol 24(4):333–344
Rippin JD, Patel A, Belyaev ND, Gill GV, Barnett AH, Bain SC (2003) Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 46(3):426–428
Ritt M, Ott C, Delles C, Schneider MP, Schmieder RE (2008) Impact of the endothelial nitric oxide synthase gene G894T polymorphism on renal endothelial function in patients with type 2 diabetes. Pharmacogenet Genomics 18(8):699–707
Santilli F, Cipollone F, Mezzetti A, Chiarelli F (2004) The role of nitric oxide in the development of diabetic angiopathy. Horm Metab Res 36(5):319–335
Schmidt HH, Walter U (1994) NO at work. Cell 78(6):919–925
Seaquist ER, Goetz FC, Rich S, Barbosa J (1989) Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320(18):1161–1165
Shi Y, Zhao X, Yu L et al (2004) Genetic structure adds power to detect schizophrenia susceptibility at SLIT3 in the Chinese Han population. Genome Res 14(7):1345–1349
Shimizu T, Onuma T, Kawamori R, Makita Y, Tomino Y (2002) Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Res Clin Pract 58(3):179–185
Shin Shin Y, Baek SH, Chang KY et al (2004) Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Diabetes Res Clin Pract 65(3):257–265
Taniwaki H, Ishimura E, Matsumoto N, Emoto M, Inaba M, Nishizawa Y (2001) Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy. Diabetes Care 24(9):1653–1660
Taverna MJ, Sola A, Guyot-Argenton C et al (2002) eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy. Diabet Med 19(3):240–245
Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J (2000) Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA 97(6):2832–2835
Tiwari AK, Prasad P, KT B et al (2009) Oxidative stress pathway genes and chronic renal insufficiency in Asian Indians with Type 2 diabetes. J Diabetes Complications 23(2):102–111
Tsukada T, Yokoyama K, Arai T et al (1998) Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 245(1):190–193
Ukkola O, Erkkila PH, Savolainen MJ, Kesaniemi YA (2001) Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Intern Med 249(5):451–459
Wang J, Dudley D, Wang XL (2002) Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol 22(5):e1–e4
Weekers L, Hadjadj S, Belloum R, Gallois Y, Bouhanick B, Marre M (1999) Lack of contribution of two endothelial nitric oxide synthase (eNOS) gene polymorphisms to diabetic nephropathy in type 1 diabetes. Diabetologia 42:A266 (Abstract)
Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19:251–253
Yamada K, Nakano H, Nakayama M et al (1995) Endothelium-dependent relaxation in peripheral vasculature and kidney of non-insulin-dependent diabetes mellitus. J Diabetes Complications 9(4):203–207
Yu W, Gwinn M, Clyne M, Yesupriya A, Khoury MJ (2008) A navigator for human genome epidemiology. Nat Genet 40(2):124–125
Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS (2000) Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 57(2):405–413
Zhao HJ, Wang S, Cheng H et al (2006) Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 17(10):2664–2669
Acknowledgments
This work was supported by Grants (2006AA02A407, 2007CB947300, 07DZ22917, 2010CB529600, and 09DJ1400601), the Shanghai Changning Health Bureau Program (2008406002), the Shanghai Municipal Health Bureau Program (2008095), and the Shanghai Leading Academic Discipline Project (B205). Special thanks are due to Dr Tiwari, Prof. T.B.K., Dr Liu, Dr Kaňková, and Prof. Marre for their help in providing the raw data and material from their earlier work.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zeng, Z., Li, L., Zhang, Z. et al. A meta-analysis of three polymorphisms in the endothelial nitric oxide synthase gene (NOS3) and their effect on the risk of diabetic nephropathy. Hum Genet 127, 373–381 (2010). https://doi.org/10.1007/s00439-009-0783-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-009-0783-x